- Home
- ELMD vs DRUG Comparison
ELMD vs DRUG Comparison
Compare ELMD & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- DRUG
- Stock Information
- Founded
- ELMD 1992
- DRUG 2019
- Country
- ELMD United States
- DRUG United States
- Employees
- ELMD N/A
- DRUG N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DRUG Pharmaceuticals and Biotechnology
- Sector
- ELMD Health Care
- DRUG Health Care
- Exchange
- ELMD Nasdaq
- DRUG Nasdaq
- Market Cap
- ELMD 172.2M
- DRUG 199.7M
- IPO Year
- ELMD 2010
- DRUG N/A
- Fundamental
- Price
- ELMD $22.05
- DRUG $24.42
- Analyst Decision
- ELMD Strong Buy
- DRUG Strong Buy
- Analyst Count
- ELMD 1
- DRUG 6
- Target Price
- ELMD $38.00
- DRUG $83.25
- AVG Volume (30 Days)
- ELMD 105.1K
- DRUG 53.2K
- Earning Date
- ELMD 05-13-2025
- DRUG 08-13-2025
- Dividend Yield
- ELMD N/A
- DRUG N/A
- EPS Growth
- ELMD 60.99
- DRUG N/A
- EPS
- ELMD 0.79
- DRUG N/A
- Revenue
- ELMD $61,439,000.00
- DRUG N/A
- Revenue This Year
- ELMD $17.91
- DRUG N/A
- Revenue Next Year
- ELMD $11.70
- DRUG N/A
- P/E Ratio
- ELMD $27.64
- DRUG N/A
- Revenue Growth
- ELMD 14.85
- DRUG N/A
- 52 Week Low
- ELMD $13.74
- DRUG $0.93
- 52 Week High
- ELMD $35.56
- DRUG $79.02
- Technical
- Relative Strength Index (RSI)
- ELMD 60.57
- DRUG 34.00
- Support Level
- ELMD $20.00
- DRUG $26.00
- Resistance Level
- ELMD $22.35
- DRUG $28.49
- Average True Range (ATR)
- ELMD 0.70
- DRUG 1.53
- MACD
- ELMD 0.28
- DRUG -0.10
- Stochastic Oscillator
- ELMD 89.09
- DRUG 14.58
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.